|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Noncurrent assets | ||||||||||||||||||||
| Mineral claims | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Promissory notes payable, net of discount | ||||||||||||||||||||
| Promissory notes payable – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total promissory notes payable – related party | ||||||||||||||||||||
| Convertible notes payable, net of discount | ||||||||||||||||||||
| Convertible notes payable – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible notes payable – related party | ||||||||||||||||||||
| Current capital lease obligation | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ deficit | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value, 100,000,000 shares authorized, 3,789,585 and 3,142,371 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Stock to be issued | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...
